FDA 510(k)

Silver Alginate Dressing (Prescription use), Antibacterial Alginate Would Dressing (OTC use)

K-Nummer: K202982 · 2021-10-19

Entscheidungsdatum2021-10-19

ProduktcodeFRO

EntscheidungSubstantially Equivalent

Produktübersicht

Silver Alginate Dressing (Prescription use), Antibacterial Alginate Would Dressing (OTC use) is the device name listed in this FDA 510(k) record. The listed applicant is Winner Medical Co., Ltd.. It received FDA 510(k) clearance on 2021-10-19 under 510(k) number K202982. The device is classified under product code FRO. Product code FRO falls under the category of Anesthesiology, which includes devices for anesthetic delivery and patient monitoring. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Häufig gestellte Fragen

What is the Silver Alginate Dressing (Prescription use), Antibacterial Alginate Would Dressing (OTC use)?

Silver Alginate Dressing (Prescription use), Antibacterial Alginate Would Dressing (OTC use) is a medical device that received FDA 510(k) clearance on 2021-10-19. The listed applicant is Winner Medical Co., Ltd.. The 510(k) number is K202982.

When did Silver Alginate Dressing (Prescription use), Antibacterial Alginate Would Dressing (OTC use) receive FDA 510(k) clearance?

Silver Alginate Dressing (Prescription use), Antibacterial Alginate Would Dressing (OTC use) received FDA 510(k) clearance on 2021-10-19, under 510(k) number K202982.

Who is the listed applicant for Silver Alginate Dressing (Prescription use), Antibacterial Alginate Would Dressing (OTC use)?

The FDA 510(k) record lists Winner Medical Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Silver Alginate Dressing (Prescription use), Antibacterial Alginate Would Dressing (OTC use)?

The FDA product code for Silver Alginate Dressing (Prescription use), Antibacterial Alginate Would Dressing (OTC use) is FRO. This falls under the Anesthesiology category.

Zugehörige klinische Studien

Zugehörige Einträge werden automatisch anhand von Namen, Produktcodes oder anderen Metadaten abgeglichen. Eine Übereinstimmung begründet kein verifiziertes klinisches, wissenschaftliches, unternehmerisches oder regulatorisches Verhältnis; prüfen Sie die verlinkten offiziellen Quellen.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Weitere Einträge mit Winner Medical Co., Ltd. als Antragsteller

K252001Collagen Wound Dressing K250082Procedure mask/Surgical mask/Face mask K231057Antibakterielles Gel Wundverband K231564Skin and Wound Cleanser K231152Collagen Wound Dressing K221311Antibakterielle Binden

Alle 18 Geräte anzeigen →

Verwandte Geräte (Code: FRO)

K254168Actolind® (06.3637. Actolind® Gel Plus)ACTO GmbH K254041SkinSmart Antimicrobial HydroGelMagic Science Supply, LLC K261646Redermax® Antibacterial Wound MatrixBeijing Kreate Medical Co., Ltd.K253665Vashe Plus Antimicrobial SolutionUrgo Medical North America, LLC K251929SilverCeuticals® Antimicrobial Wound GelSilverceuticals, Inc.K261023Microdacyn Wound Irrigation SolutionSonoma Pharmaceuticals, Inc.

Offizielle Quelle

In der FDA-Datenbank anzeigen →

Daten aus der FDA Open API. Für die aktuellsten und verbindlichen Informationen konsultieren Sie bitte stets den offiziellen Datensatz.